There is a great need for therapies to prevent and/or slow the progression of AD. The major challenge in AD drug development is lack of clarity about the mechanisms underlying AD pathogenesis and pathophysiology. Several studies support the notion that AD is a multifactorial disease.

#Braindisorders #Mentalhealth #Pediatricneurology #braincancer 

#Contactinfo:+44 1303 610264

#https://braindisorders.neurologyconference.com/

#braindisorder@euroannualmeetings.com